Scientists hunt for blood clue to Meth-Induced madness
NCT ID NCT07434401
Summary
This study aimed to understand if a specific enzyme in the blood is linked to psychotic symptoms in people who use methamphetamine. Researchers compared blood levels of this enzyme in three groups: people with methamphetamine use disorder, those with methamphetamine-induced psychosis, and healthy individuals. The goal was to see if this marker could help identify or understand the risk of developing psychosis.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METHAMPHETAMINE USE DISORDER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Elazığ Mental Health and Diseases Hospital
Elâzığ, Elâzığ, 23200, Turkey (Türkiye)
Conditions
Explore the condition pages connected to this study.